Fujifilm CorporationSeptember 22, 2023

FDA 483 - Fujifilm Corporation - September 22, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Fujifilm Corporation

Record Details

Fujifilm Corporation, a medical device manufacturer in Ashigarakami-Gun, Japan, was cited for three observations during an FDA inspection. The firm failed to adequately establish corrective and preventive action procedures, including missing documentation for design transfers and complaint reviews. Additionally, the company submitted Medical Device Reports (MDRs) with incomplete information, specifically regarding the manufacturing site and patient identifiers.

Company: Fujifilm Corporation
Inspection Date: September 22, 2023
Product Type: Device
Office: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
Person: Thai T. Duong

Open in Dashboard

ID · e6d1516f-a0ee-4183-b144-fb1dd013eafa